These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

108 related articles for article (PubMed ID: 15090787)

  • 21. Prediction of HIV drug resistance based on virologic, immunologic, clinical, and/or adherence criteria in the Stratall ANRS 12110/ESTHER trial in Cameroon.
    Boullé C; Kouanfack C; Laborde-Balen G; Aghokeng AF; Boyer S; Carrieri MP; Kazé S; Mben JM; Dontsop M; Spire B; Peeters M; Mpoudi-Ngolé E; Delaporte E; Laurent C;
    Clin Infect Dis; 2013 Aug; 57(4):604-7. PubMed ID: 23667264
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Definition of loss of virological response in trials of antiretroviral drugs.
    Staszewski S; Sabin C; Dauer B; Lepri AC; Phillips A
    AIDS; 2003 Sep; 17(13):1997-8. PubMed ID: 12960838
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Antiretroviral resistance patterns and factors associated with resistance in adult patients failing NNRTI-based regimens in the Western Cape, South Africa.
    van Zyl GU; van der Merwe L; Claassen M; Zeier M; Preiser W
    J Med Virol; 2011 Oct; 83(10):1764-9. PubMed ID: 21837793
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Drugs for HIV infection.
    Treat Guidel Med Lett; 2011 Jun; 9(106):29-40. PubMed ID: 21617596
    [No Abstract]   [Full Text] [Related]  

  • 25. Running with scissors: using antiretroviral therapy without monitoring viral load.
    Smith DM; Schooley RT
    Clin Infect Dis; 2008 May; 46(10):1598-600. PubMed ID: 18419496
    [No Abstract]   [Full Text] [Related]  

  • 26. Antiretroviral therapy for HIV: drug resistance and sequencing.
    Burkle WS
    J Assoc Nurses AIDS Care; 2002; 13(1):76-80. PubMed ID: 11828862
    [No Abstract]   [Full Text] [Related]  

  • 27. SP-01A helps with quality of life.
    AIDS Patient Care STDS; 2008 Feb; 22(2):160-1. PubMed ID: 18273942
    [No Abstract]   [Full Text] [Related]  

  • 28. Treatment of antiretroviral-drug-resistant HIV-1 infection.
    Deeks SG
    Lancet; 2003 Dec; 362(9400):2002-11. PubMed ID: 14683662
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Preventing and managing antiretroviral drug resistance.
    Kuritzkes DR
    AIDS Patient Care STDS; 2004 May; 18(5):259-73. PubMed ID: 15186710
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Low Incidence of HIV-1C Acquired Drug Resistance 10 Years after Roll-Out of Antiretroviral Therapy in Ethiopia: A Prospective Cohort Study.
    Mulu A; Maier M; Liebert UG
    PLoS One; 2015; 10(10):e0141318. PubMed ID: 26512902
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Treatment failure and drug resistance in HIV-positive patients on tenofovir-based first-line antiretroviral therapy in western Kenya.
    Brooks K; Diero L; DeLong A; Balamane M; Reitsma M; Kemboi E; Orido M; Emonyi W; Coetzer M; Hogan J; Kantor R
    J Int AIDS Soc; 2016; 19(1):20798. PubMed ID: 27231099
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Enduringly effective and tolerable initial therapy of HIV. Even after 5 years no resistance].
    MMW Fortschr Med; 2003 Dec; 145(50):60-1. PubMed ID: 14963980
    [No Abstract]   [Full Text] [Related]  

  • 33. Prevalence and predictive value of intermittent viremia with combination hiv therapy.
    Havlir DV; Bassett R; Levitan D; Gilbert P; Tebas P; Collier AC; Hirsch MS; Ignacio C; Condra J; Günthard HF; Richman DD; Wong JK
    JAMA; 2001 Jul; 286(2):171-9. PubMed ID: 11448280
    [TBL] [Abstract][Full Text] [Related]  

  • 34. A qualitative PCR minipool strategy to screen for virologic failure and antiretroviral drug resistance in South African patients on first-line antiretroviral therapy.
    Newman H; Breunig L; van Zyl G; Stich A; Preiser W
    J Clin Virol; 2014 Aug; 60(4):387-91. PubMed ID: 24929754
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Predictors of virologic failure and resistance in HIV-infected patients treated with nevirapine- or efavirenz-based antiretroviral therapy.
    Parienti JJ; Massari V; Descamps D; Vabret A; Bouvet E; Larouzé B; Verdon R
    Clin Infect Dis; 2004 May; 38(9):1311-6. PubMed ID: 15127346
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Choice of an initial antiretroviral regimen in the resource-limited setting: the cost of virologic failure.
    Campbell TB
    Clin Infect Dis; 2008 Sep; 47(5):723-5. PubMed ID: 18662135
    [No Abstract]   [Full Text] [Related]  

  • 37. Chronic HIV infection: can anyone afford a drug holiday?
    Kane B
    Ann Intern Med; 2002 Aug; 137(4):301-4. PubMed ID: 12186535
    [No Abstract]   [Full Text] [Related]  

  • 38. First-line HIV therapy shall not fail.
    Boucher C; Vella S
    Lancet HIV; 2016 Mar; 3(3):e108-9. PubMed ID: 26939732
    [No Abstract]   [Full Text] [Related]  

  • 39. The association between primary antiretroviral resistance and HAART virologic failure in a developing set.
    Gagliani LH; Alkmim Maia WT; Sá-Filho D; Janini LM; Sucupira MC; Caseiro MM; Diaz RS
    AIDS Res Hum Retroviruses; 2011 Mar; 27(3):251-6. PubMed ID: 20977353
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Less than the sum of its parts: failure of a tenofovir-abacavir-Lamivudine triple-nucleoside regimen.
    Kuritzkes DR
    J Infect Dis; 2005 Dec; 192(11):1867-8. PubMed ID: 16267755
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.